PRESS RELEASE published on 01/24/2024 at 07:00, 1 year 11 months ago Mikron achieves marked increase in net sales with high order backlog Mikron Holding AG has announced a significant increase in net sales and high order backlog for the 2023 financial year, with the Group exceeding the previous year's results. The strong demand in pharmaceutical and medical technology industries, coupled with good performance in all three divisions, contributed to this positive development. The Group expects further improvement in profitability compared to the previous year and will release detailed figures for 2023 on March 8, 2024. Financial Results Pharmaceutical Industry Mikron Holding AG Net Sales Increase Order Backlog
PRESS RELEASE published on 01/24/2024 at 06:30, 1 year 11 months ago Rieter: First Information on the Financial Year 2023 Ad-hoc announcement pursuant to Art. 53 LR Rieter Holding AG has released a preliminary update on the Financial Year 2023, as part of an ad-hoc announcement. The media and investor presentation is available in the attached media kit. Investor Presentation Financial Year 2023 Rieter Holding AG Ad-hoc Announcement Media Kit
PRESS RELEASE published on 01/24/2024 at 03:59, 1 year 11 months ago Update - WPF Holdings Updates Prospects for 2024 WPF Holdings, Inc provides updates on its 2024 current projects and the status of several transactions initiated at the end of 2023, including the integration of the digital wallet, expansion of partnership with Woohoo, sales partnership for mobile devices and tablets, anticipated launch of live and streaming television services, and the acquisition of Virtual Health Holdings, Inc. The company also announces additional acquisitions agreements and emphasizes forward-looking statements in this regard. Telemedicine WPF Holdings 2024 Projects Digital Wallet Integration Acquisitions Agreements
PRESS RELEASE published on 01/24/2024 at 02:03, 1 year 11 months ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIVI The Rosen Law Firm, a trusted and leading law firm, is announcing a class action lawsuit on behalf of BioVie Inc. investors. The lawsuit alleges that BioVie made misleading statements about its business operations and COVID-19's impact on its clinical trial sites, resulting in damages to investors. If you purchased BioVie securities during the specified period, you may be entitled to compensation. Investors are encouraged to seek qualified counsel and can join the class action by contacting The Rosen Law Firm before the important deadline on March 19, 2024. Rosen Law Firm Securities Class Action Investor Rights Financial Litigation BioVie Inc.
PRESS RELEASE published on 01/24/2024 at 02:03, 1 year 11 months ago ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of AlloVir, Inc. If you purchased AlloVir securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Join the AlloVir class action by visiting the link provided or contacting the stated email and phone numbers for information. The lawsuit alleges that AlloVir made materially false and misleading statements regarding its business, operations, and prospects, leading to damages for investors. Securities Investors Rosen Law Firm Class Action Lawsuit AlloVir
PRESS RELEASE published on 01/24/2024 at 02:02, 1 year 11 months ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX The Rosen Law Firm, a global investor rights law firm, is encouraging Eagle Pharmaceuticals, Inc. investors to seek counsel before the important deadline in the securities class action. Investors who purchased Eagle Pharmaceuticals securities during the specified period may be entitled to compensation without payment of out-of-pocket fees through a contingency fee arrangement. The firm has a track record of success in leadership roles and represents investors in securities class actions and shareholder derivative litigation. For more information on the class action or to join, visit the provided website or contact the firm directly. The lawsuit claims that investors suffered damages, and no class has been certified yet. Rosen Law Firm Securities Class Action Investor Rights Eagle Pharmaceuticals Shareholder Derivative Litigation
PRESS RELEASE published on 01/24/2024 at 02:00, 1 year 11 months ago Orkid Announces Commercial Partnership in Vietnam With TPComs Orkid, a visionary Generative AI SaaS vendor, has announced a strategic commercial partnership with TPComs, a leading ICT service provider in Vietnam. The partnership aims to bring cutting-edge Generative A.I. automation solutions to the Vietnamese market, leveraging Vietnam's efforts to embrace digitalization and automation. Through this collaboration, organizations in Vietnam can now access advanced automation solutions for back-end operations supported by Orkid's AI-powered hyper-automation models. Generative AI Automation Solutions Orkid Vietnam ICT Service Provider
PRESS RELEASE published on 01/24/2024 at 01:07, 1 year 11 months ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DRVN The Rosen Law Firm, a global investor rights law firm, is encouraging Driven Brands Holdings Inc. investors with losses to secure counsel before the important February 20, 2024 lead plaintiff deadline. The firm represents investors throughout the globe, with a focus on securities class actions and shareholder derivative litigation, and has a strong track record of success in securing settlements for investors in similar cases. Investors who purchased Driven Brands common stock during the specified period may be entitled to compensation without payment of any out-of-pocket fees through a contingency fee arrangement. For more information on the class action and how to join, visit the Rosen Law Firm's website or contact the firm directly. They emphasize the importance of selecting qualified counsel with a proven record of success in these types of litigation. The lawsuit alleges that the defendants made materially false and misleading statements and omissions regarding the integration of acquired businesses and the performance of the car wash business segment, causing damages to investors. The Rosen Law Firm emphasizes that no class has been certified at this time, and investors may select their own counsel or remain as absent class members. Follow the Rosen Law Firm on social media for updates and news related to the case. Investors Rosen Law Firm Securities Class Action Driven Brands Holdings Inc. Shareholder Derivative Litigation
PRESS RELEASE published on 01/24/2024 at 01:07, 1 year 11 months ago ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and October 13, 2023. Investors are encouraged to secure counsel before the important deadline in this securities class action. The Rosen Law Firm represents investors globally in securities class actions and shareholder derivative litigation, with a track record of successful settlements. If you wish to join the BioNTech class action, visit the website or contact for more information. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights Financial Lawsuit
PRESS RELEASE published on 01/24/2024 at 01:00, 1 year 11 months ago Cask Welcomes Jeff Butler as General Manager for New Canadian Branch Cask, a leading ServiceNow partner, is expanding its international presence with the appointment of Jeff Butler as the General Manager of its newly established Canadian branch. With over seven years of experience in the ServiceNow ecosystem, Butler is poised to lead Cask's Canadian operations and drive innovative solutions for clients in the growing digital transformation market in Canada. Digital Transformation Cask ServiceNow Partner Canadian Market Jeff Butler
Published on 01/14/2026 at 08:05, 3 hours 42 minutes ago Tocvan Strengthens Board with Appointment of Anna Ladd-Kruger
Published on 01/14/2026 at 08:00, 3 hours 47 minutes ago Caledonia Mining Corporation Plc Change in Executive Management
Published on 01/14/2026 at 04:05, 7 hours 42 minutes ago Usha Resources and Totec Resources Announce TSXV Conditional Acceptance and Filing of Filing Statement for Qualifying Transaction
Published on 01/14/2026 at 11:34, 12 minutes ago Sartorius expands bio-circular product offering for more sustainable bioprocesses
Published on 01/14/2026 at 11:06, 41 minutes ago LAIQON AG enters 2026 with strengthened management team
Published on 01/14/2026 at 10:35, 1 hour 11 minutes ago osapiens secures US$ 100 million Financing and Becomes a Unicorn with investment from BlackRock- and Temasek-founded Decarbonization Partners
Published on 01/14/2026 at 10:26, 1 hour 20 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 01/14/2026 at 08:45, 3 hours 2 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st 2026
Published on 01/14/2026 at 08:45, 3 hours 2 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st, 2026
Published on 01/14/2026 at 08:45, 3 hours 2 minutes ago Arnaud Lagardère est nommé Président non exécutif de Lagardère Travel Retail. Frédéric Chevalier succède à Dag Rasmussen à compter du 1er mars 2026.
Published on 01/13/2026 at 18:27, 17 hours 19 minutes ago 260113 BENETEAU Déclaration du nombre d'actions et de droits de vote au 31-12-2025